PROTAC Linker

Biotin-PEG6-amine is a polyethylene glycol (PEG)-based linker designed for use in the synthesis of PROTACs (proteolysis-targeting chimeras). It facilitates the conjugation of biotin moieties to protein targets, thereby enhancing the accessibility of the target for ubiquitination. This compound is crucial for developing novel therapeutic strategies involving targeted protein degradation, enabling researchers to investigate protein function and pathway modulation in various cellular contexts.

Ald-Ph-PEG5-Boc is a PEG-based PROTAC linker designed for the synthesis of proteolysis-targeting chimeras (PROTACs). This compound facilitates the effective conjugation of ligands to target proteins, thereby promoting targeted degradation. Ald-Ph-PEG5-Boc is instrumental in advancing research on targeted protein degradation and optimizing PROTAC development for therapeutic applications.

m-PEG3-amido-C3-triethoxysilane is a polyethylene glycol (PEG)-based linker designed for PROTAC (Proteolysis Targeting Chimeras) applications. This compound facilitates the synthesis of PROTACs by providing a flexible and biocompatible moiety that can enhance the efficacy of targeted protein degradation. Its unique structure allows for optimized binding and stability, making it a valuable tool in chemical biology and drug discovery.

DNP-PEG3-DNP is a polyethylene glycol (PEG) based linker designed for use in PROTAC (proteolysis-targeting chimeras) synthesis. This compound facilitates the effective conjugation of targeting and E3 ligase recruiting moieties essential for targeted protein degradation. DNP-PEG3-DNP is pivotal in the development of novel therapeutic approaches aimed at modulating protein levels in various biological contexts.

Thiol-PEG6-acid is a PEG-based linker specifically designed for use in PROTAC (PROteolysis TArgeting Chimeras) synthesis. This compound facilitates the conjugation of target proteins to E3 ligases, promoting targeted degradation via the ubiquitin-proteasome pathway. Its applications extend to advancing research in protein degradation, targeted therapy development, and chemical biology.

HS-PEG7-CH2CH2COOH is a polyethylene glycol (PEG)-based linker ideal for use in the synthesis of proteolysis-targeting chimeras (PROTACs). This compound facilitates the conjugation of targeting moieties to ubiquitin ligase components, enhancing the efficacy of targeted protein degradation. It serves as a versatile tool for researchers investigating the modulation of protein levels in various biological systems.

m-PEG12-2-methylacrylate is a polyethylene glycol (PEG)-based linker designed for use in the synthesis of proteolysis-targeting chimeras (PROTACs). This compound facilitates the conjugation of target proteins with E3 ligases, enhancing the degradation of specific proteins through the ubiquitin-proteasome system. Its application in PROTAC development underscores its importance in studying protein function, cellular signaling pathways, and potential therapeutic interventions.

Mal-amido-PEG9-NHS ester is a PEG-based linker specifically designed for use in the synthesis of PROTACs (Proteolysis Targeting Chimeras). This compound facilitates the formation of conjugates by providing a stable chemical connection between target proteins and E3 ligases, thus enhancing targeted protein degradation. Its unique structure supports various biological applications in drug discovery and therapeutic development, making it an essential reagent for researchers exploring novel PROTAC modalities.

S-acetyl-PEG5-alcohol is a polyethylene glycol (PEG)-based linker specifically designed for PROTAC (proteolysis-targeting chimeras) synthesis. This compound enhances the solubility and pharmacokinetic properties of PROTAC molecules, enabling targeted degradation of proteins. It serves as a valuable tool in chemical biology and drug discovery research, facilitating the development of innovative therapeutic agents.

N-(Amino-PEG4)-N-bis(PEG4-Boc) is a PEG-based PROTAC linker designed for the synthesis of proteolysis-targeting chimeras (PROTACs). This compound facilitates the development of targeted protein degradation strategies by providing optimal solubility and flexibility in the linker design. N-(Amino-PEG4)-N-bis(PEG4-Boc) is suitable for applications in cellular and molecular research aimed at modulating protein levels and studying associated biological processes.

Cl-PEG6-acid is a PEG-based linker specifically designed for use in the synthesis of PROTACs (Proteolysis Targeting Chimeras). This compound facilitates the selective degradation of target proteins by linking E3 ligases to the protein of interest, thus enhancing the therapeutic potential in targeted protein degradation studies. Cl-PEG6-acid is suitable for a range of research applications, including drug discovery and the development of novel therapeutic strategies.

1,1,1-Trifluoroethyl-PEG4-aminooxy is a polyethylene glycol (PEG)-based linker designed for use in the synthesis of PROTAC (proteolysis-targeting chimeras). This compound facilitates the conjugation of ligands for targeted protein degradation, enabling selective modulation of protein levels in biological systems. Its unique structure supports efficient and stable interactions, making it suitable for research applications in drug development and cellular biology studies focused on degrading specific proteins.

m-PEG3-S-Acetyl is a PEG-derived linker designed for use in the synthesis of PROTACs (Proteolysis Targeting Chimeras). This compound facilitates the conjugation of the targeting ligand to the E3 ubiquitin ligase, enhancing the degradation of specific proteins within cells. Its application is crucial for researchers developing targeted protein degradation technologies to explore cellular mechanisms and therapeutic interventions.

TCO-PEG4-TCO is a PEG-based linker designed for use in PROTAC (Proteolysis Targeting Chimera) synthesis. This compound plays a crucial role in facilitating the targeted degradation of specific proteins, enabling the development of novel therapeutic strategies. Its application in research underscores its importance in the fields of protein modulation and targeted therapy.

m-PEG5-Boc is a PEG-based PROTAC linker that facilitates the synthesis of proteolysis-targeting chimeras (PROTACs). This compound effectively enhances the solubility and stability of the PROTAC molecule, promoting efficient protein degradation. It is particularly valuable in chemical biology research for the development of targeted protein degradation strategies.

Boc-NH-PEG20-CH2CH2COOH is a PEG-derived linker designed for use in the synthesis of proteolysis-targeting chimeras (PROTACs). This compound facilitates the recruitment of E3 ligases to specific target proteins, enabling targeted degradation pathways. Its unique chemical structure enhances solubility and stability, making it an essential tool for researchers investigating ubiquitin-proteasome system modulation and targeted protein degradation applications.

Iodoacetyl-PEG4-NHS ester is a PEG-based linker designed for the synthesis of PROTACs (proteolysis-targeting chimeras). This compound contains an iodoacetyl group that facilitates efficient conjugation to target proteins, enabling targeted degradation through the ubiquitin-proteasome system. Its versatility in forming stable linkages makes it valuable for researchers investigating targeted protein degradation and related therapeutic applications.

Boc-aminooxy-PEG2-propargyl is a PEG-based linker designed for the synthesis of PROTACs (proteolysis-targeting chimeras). It features an alkyne functional group, enabling it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) reactions with azide-containing molecules. This compound is essential for developing targeted protein degradation strategies and facilitates the construction of complex molecular architectures in chemical biology research.

N-(Aminooxy-PEG3)-N-bis(PEG4-Boc) is a PEG-based linker designed for use in the synthesis of PROTACs (proteolysis-targeting chimeras). This compound facilitates the conjugation of a target protein to an E3 ligase, enabling targeted protein degradation. Its construction of aminooxy and Boc-protected entities allows for functionalization and versatility in drug design, making it a valuable tool for researchers exploring targeted therapies and protein modulation.

Ethyl-PEG4-alcohol is a polyethylene glycol (PEG)-based linker utilized in the synthesis of PROTACs (Proteolysis Targeting Chimeras). This compound enhances solubility and facilitates the efficient conjugation of a target protein ligand with an E3 ligase ligand, enabling selective degradation of target proteins. It is primarily applied in chemical biology and drug discovery to investigate protein function and modulation.

3-Maleimidopropionic acid is a versatile linker designed for use in the synthesis of PROTACs (Proteolysis Targeting Chimeras). Its maleimide functional group allows for the selective formation of thioether bonds with cysteine residues, facilitating targeted protein degradation. This compound is instrumental in advancing research in cellular signaling pathways and drug discovery by enabling the development of innovative therapeutics.

Biotin-EDA is an alkyl chain-based linker specifically designed for use in the synthesis of PROTACs (proteolysis-targeting chimeras). This compound facilitates targeted protein degradation by connecting E3 ligases to the protein of interest. Its unique structure enhances the efficiency of PROTAC development, making it a valuable tool in drug discovery and development for therapeutic interventions. Biotin-EDA is particularly useful in studies involving targeted therapeutics and protein regulation mechanisms.

Mal-NH2 TFA is an alkyl chain-based PROTAC linker designed for the synthesis of PROTACs (proteolysis-targeting chimeras). This compound facilitates the development of bifunctional molecules that can selectively target and degrade specific proteins within the cell. Its application is crucial in various research areas, including drug discovery and the investigation of protein function and degradation pathways.

Biotin-bis-amido-SS-NHS is a versatile PROTAC linker designed for targeted protein degradation applications. This compound facilitates the synthesis of PROTACs by enabling efficient conjugation to target proteins, leveraging the biotin-streptavidin interaction for cellular applications. Its unique structure enhances stability and biocompatibility, making it suitable for diverse research purposes in drug discovery and cellular biology.

CH2COOH-PEG6-CH2COOH is a polyethylene glycol (PEG)-based linker designed for use in the synthesis of PROTACs (proteolysis targeting chimeras). This compound facilitates the conjugation of target proteins and E3 ligase, enhancing the degradation of specific proteins through the ubiquitin-proteasome pathway. Its application is significant in drug discovery research, particularly in the development of targeted protein degradation therapies.

Icosane-1,20-diol serves as a versatile PROTAC linker, facilitating the development of proteolysis-targeting chimeras (PROTACs) for targeted protein degradation. Its unique structure enhances the molecular design of PROTACs, optimizing their biological activity and efficacy. This reagent is essential for researchers aiming to explore targeted therapies and investigate protein regulation mechanisms in various biological contexts.

2-(Benzyloxy)ethanol is a PEG-based PROTAC linker utilized in the synthesis of proteolysis-targeting chimeras (PROTACs). This compound provides a flexible and functional scaffold, facilitating the efficient degradation of target proteins through the ubiquitin-proteasome system. Its application in chemical biology enables researchers to explore targeted protein degradation mechanisms and therapeutic strategies.

Diethyl nonanedioate, also known as diethyl azelate, serves as a versatile PROTAC linker essential for the synthesis of Proteolysis Targeting Chimeras (PROTACs). This compound facilitates the selective degradation of target proteins via the ubiquitin-proteasome system, enabling researchers to investigate protein function and modulation. Its application in PROTAC development aids in the advancement of targeted therapy strategies in various diseases, including cancer and neurodegenerative disorders.

3-tert-Butyl-4-methoxyphenol serves as a PROTAC linker, facilitating targeted protein degradation. This compound exhibits unique biological activity, including insecticidal effects, and has been shown to enhance the activities of glutathione S-transferase and epoxide hydrolase in liver and forestomach tissues of A/HeJ mice. Its ability to regulate carcinogen metabolism makes it a valuable tool for research applications in cellular signaling and toxicology studies.

Cis-ethyl (1R,2S)-2-cyanocyclopropane-1-carboxylate is a versatile PROTAC linker designed for the synthesis of proteolysis-targeting chimeras (PROTACs). This compound facilitates the selective degradation of target proteins through the ubiquitin-proteasome system. Its unique structural features allow for enhanced binding specificity and efficacy in targeted protein degradation research applications.

1,3-Dibromo-5,5-dimethylhydantoin serves as an efficient alkyl chain-based PROTAC linker, facilitating the development of proteolysis-targeting chimeras (PROTACs). Its unique structure enables selective degradation of target proteins, making it a valuable tool in chemical biology research. This compound is crucial for researchers focused on novel therapeutic strategies involving targeted protein degradation.

1,6-Diiodohexane is a bifunctional linker designed for use in PROTAC (Proteolysis Targeting Chimeras) synthesis. Its unique structure facilitates the conjugation of target proteins to E3 ligases, enhancing the recruitment and degradation of specific proteins within the cell. This compound is valuable for researchers investigating targeted protein degradation mechanisms and developing novel therapeutics in protein homeostasis studies.

trans-1,4-Cyclohexanediamine serves as a versatile PROTAC linker, facilitating the development of targeted protein degradation tools. Its unique structure enhances the efficiency of PROTACs by promoting the selective degradation of target proteins via the ubiquitin-proteasome pathway. This compound is essential for researchers investigating novel therapeutic strategies in cancer and other diseases through protein modulation.